Crescent Capital BDC (CCAP) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
6 May, 2026Executive summary
Net investment income per share was $0.46 for Q3 2025, unchanged from the prior quarter, while net income per share declined to $0.19 from $0.41 sequentially; net asset value (NAV) per share was $19.28 as of September 30, 2025, down from $19.55 in Q2 and $19.98 at year-end 2024.
Portfolio consisted of 187 companies, with $1.6 billion in investments, 97.4% of debt investments at floating rates, and 90% in first-lien or unitranche first lien loans.
Board declared a regular Q4 2025 dividend of $0.42 per share, marking the 39th consecutive quarter of earning the regular dividend, and paid a final special dividend of $0.05 per share for Q3 2025.
Net assets as of September 30, 2025, were $714 million.
Financial highlights
Net investment income for Q3 2025 was $16.9 million ($0.46/share), flat sequentially but down from $23.5 million ($0.64/share) in Q3 2024; net income per share was $0.19, down from $0.41 in the prior quarter.
Investment income for Q3 2025 was $41.4 million, down from $43.0 million in Q2 2025 and $51.6 million in Q3 2024.
Net realized and unrealized losses on investments totaled $(9.8) million or $(0.27) per share in Q3 2025.
Total expenses for Q3 2025 were $24.2 million, down from $27.4 million in Q3 2024, mainly due to lower interest and debt financing costs.
Distributions declared in Q3 2025 totaled $0.42 per share, consistent with prior quarters.
Outlook and guidance
Management anticipates a lower base rate environment may reduce portfolio yields and pressure NII, but expects to cover the base dividend with NII in the near term.
Board declared a Q4 2025 regular cash dividend of $0.42 per share, consistent with prior quarters and payable January 15, 2026.
Recent amendments to credit facilities reduced borrowing costs and extended maturities, supporting future liquidity.
Expects increased origination and structuring fees, and higher non-interest-related income as deal activity picks up.
Sees a larger opportunity set for new investments over the next 12 months, supported by a robust origination pipeline.
Latest events from Crescent Capital BDC
- Q4 net investment income covered the dividend, with NAV at $19.10 and a strong, diversified portfolio.CCAP
Q4 20256 Apr 2026 - Virtual meeting to elect directors and ratify auditor, with online voting available.CCAP
Proxy filing1 Apr 2026 - Virtual meeting to elect directors and ratify E&Y as auditor, with strong governance oversight.CCAP
Proxy filing1 Apr 2026 - Q2 2024 NII reached $0.59/share, NAV $20.30, with strong liquidity and stable credit.CCAP
Q2 20241 Feb 2026 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 202414 Jan 2026 - Q4 2024 featured lower NII, stable NAV, robust liquidity, and special dividends for 2025.CCAP
Q4 202424 Dec 2025 - Board urges ratification of Ernst & Young LLP as auditor, with 2024 fees totaling $841,150.CCAP
Proxy Filing2 Dec 2025 - Director elections and auditor ratification headline the 2025 annual meeting agenda.CCAP
Proxy Filing2 Dec 2025 - Stockholders will vote virtually on director elections and auditor ratification, with strong board oversight.CCAP
Proxy Filing2 Dec 2025